24 September 2025 | 3:16PM CST Mindray (300760.SZ) FAQs: Growth target after normalization; new growth engine from recurring revenue Triggered by the anti-corruption campaign in 3Q23, China's hospital capital equipment market entered a downward cycle, ending the boom years that occurred during COVID-19 healthcare infrastructure expansion. Additionally, Mindray's IVD business, which has been the company's growth engine for years and accounts for nearly half of its China revenue, has also been facing pricing ...